Literature DB >> 25758847

Oral squamous cell carcinoma in a patient with keratitis-ichthyosis-deafness syndrome: a rare case.

L Homeida1, R T Wiley2, M Fatahzadeh3.   

Abstract

Keratitis-ichthyosis-deafness (KID) syndrome is a rare form of ectodermal dysplasia with significant visual and auditory impairment. Pathogenesis involves a mutation in the GJB2 gene, which encodes connexin-26, a protein in the epithelial gap junctions thought to be involved in the differentiation of ectodermally derived tissues. Affected patients are also at increased risk for the epithelial malignancies. To our knowledge, nearly 100 cases of KID syndrome, including 19 with squamous cell carcinoma (SCC) complications, have been reported worldwide. We report here a patient with KID syndrome who developed an ulcerative oral lesion causing him significant discomfort; he was subsequently diagnosed with oral SCC. We review the clinical presentation and symptomatology, including those affecting the oral cavity for this syndrome and highlight the importance of multidisciplinary collaboration and life-long screening aimed at prevention of the evolving complications. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25758847     DOI: 10.1016/j.oooo.2015.01.005

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  3 in total

1.  Connexin hemichannels influence genetically determined inflammatory and hyperproliferative skin diseases.

Authors:  Noah A Levit; Thomas W White
Journal:  Pharmacol Res       Date:  2015-07-23       Impact factor: 7.658

Review 2.  Connexins and the Epithelial Tissue Barrier: A Focus on Connexin 26.

Authors:  Laura Garcia-Vega; Erin M O'Shaughnessy; Ahmad Albuloushi; Patricia E Martin
Journal:  Biology (Basel)       Date:  2021-01-14

3.  Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors.

Authors:  Sara Akhavanfard; Roshan Padmanabhan; Lamis Yehia; Feixiong Cheng; Charis Eng
Journal:  Nat Commun       Date:  2020-05-05       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.